Mariner

Mariner’s Amneal Pharmaceuticals AMRX Stock Holding History

Mariner’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.92M	Sell	315,554 -29,639	-9%	-$398K	﹤0.01%	1153
2025 Q4	$4.35M	Sell	345,193 -49,897	-13%	-$571K	0.01%	1065
2025 Q3	$3.95M	Sell	395,090 -4,421	-1%	-$39.7K	0.01%	1040
2025 Q2	$3.23M	Buy	399,511 +5,988	+2%	+$45.1K	﹤0.01%	1068
2025 Q1	$3.3M	Sell	393,523 -30,768	-7%	-$257K	0.01%	975
2024 Q4	$3.36M	Buy	424,291 +413,268	+3,749%	+$3.47M	0.01%	955
2024 Q3	$91.7K	Buy	11,023 +469	+4%	+$3.67K	﹤0.01%	3106
2024 Q2	$67K	Buy	10,554 +294	+3%	+$1.87K	﹤0.01%	3013
2024 Q1	$62.2K	Sell	10,260 -4	-0%	-$23	﹤0.01%	3002
2023 Q4	$62.3K	Buy	+10,264	New	+$45.7K	﹤0.01%	2920

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return